Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherShort Communication

POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER

Yasuna Kobayashi, Ryoko Sakai, Naomi Ohshiro, Masayuki Ohbayashi, Noriko Kohyama and Toshinori Yamamoto
Drug Metabolism and Disposition May 2005, 33 (5) 619-622; DOI: https://doi.org/10.1124/dmd.104.003301
Yasuna Kobayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryoko Sakai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi Ohshiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Ohbayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriko Kohyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshinori Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 5 619-622
DOI 
https://doi.org/10.1124/dmd.104.003301
PubMed 
15708966

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 13, 2004
  • Accepted February 9, 2005
  • Published online April 13, 2005.

Article Versions

  • Earlier version (February 11, 2005 - 07:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yasuna Kobayashi,
  2. Ryoko Sakai,
  3. Naomi Ohshiro,
  4. Masayuki Ohbayashi,
  5. Noriko Kohyama and
  6. Toshinori Yamamoto
  1. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan (Y.K., R.S., M.O., N.K., T.Y.); and Department of Physiology and Biophysics, the University of Texas Medical Branch at Galveston, Galveston, Texas (N.O.)
  1. Address correspondence to:
    Dr. Toshinori Yamamoto, Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555. E-mail: yamagen{at}pharm.showa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201741612
Sep 20178159
Oct 2017692
Nov 20176328
Dec 20174209
Jan 20182315
Feb 20185196
Mar 20183184
Apr 20180252
May 201862212
Jun 20182142
Jul 20180129
Aug 2018094
Sep 2018074
Oct 201801313
Nov 201801112
Dec 2018923
Jan 201929159
Feb 20191625
Mar 20191665
Apr 20191942
May 20191011
Jun 20191306
Jul 20191201
Aug 20191611
Oct 20191110
Nov 20191811
Dec 20193162
Jan 20201630
Feb 2020810
Mar 20201532
May 2020511
Jun 20201133
Jul 20201010
Aug 2020806
Sep 2020660
Oct 202015143
Nov 2020741
Dec 20201211
Jan 202120122
Feb 20219102
Mar 20212242
Apr 20211820
May 20211231
Jun 20211460
Jul 20211440
Aug 2021950
Sep 20211041
Oct 2021530
Nov 20211521
Dec 20212830
Jan 20221020
Feb 2022120
Mar 2022842
Apr 2022610
May 20221320
Jun 20221610
Jul 20221720
Aug 20221871
Sep 20221320
Oct 20221460
Nov 20221010
Dec 2022910
Jan 20232260
Feb 20231151
Mar 20231030

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (5)
Drug Metabolism and Disposition
Vol. 33, Issue 5
1 May 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherShort Communication

POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER

Yasuna Kobayashi, Ryoko Sakai, Naomi Ohshiro, Masayuki Ohbayashi, Noriko Kohyama and Toshinori Yamamoto
Drug Metabolism and Disposition May 1, 2005, 33 (5) 619-622; DOI: https://doi.org/10.1124/dmd.104.003301

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherShort Communication

POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER

Yasuna Kobayashi, Ryoko Sakai, Naomi Ohshiro, Masayuki Ohbayashi, Noriko Kohyama and Toshinori Yamamoto
Drug Metabolism and Disposition May 1, 2005, 33 (5) 619-622; DOI: https://doi.org/10.1124/dmd.104.003301
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics